These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26871468)

  • 1. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
    Carrero ZI; Kollareddy M; Chauhan KM; Ramakrishnan G; Martinez LA
    Oncotarget; 2016 Mar; 7(11):12554-67. PubMed ID: 26871468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 cooperates with ETS2 to promote etoposide resistance.
    Do PM; Varanasi L; Fan S; Li C; Kubacka I; Newman V; Chauhan K; Daniels SR; Boccetta M; Garrett MR; Li R; Martinez LA
    Genes Dev; 2012 Apr; 26(8):830-45. PubMed ID: 22508727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
    Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
    J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
    Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.
    Baert JL; Monte D; Verreman K; Degerny C; Coutte L; de Launoit Y
    Oncogene; 2010 Mar; 29(12):1810-20. PubMed ID: 20062082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2.
    Plotnik JP; Hollenhorst PC
    Nucleic Acids Res; 2017 May; 45(8):4452-4462. PubMed ID: 28119415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleocapsid protein facilitates p53 ubiquitination-dependent proteasomal degradation via recruiting host ubiquitin ligase COP1 in PEDV infection.
    Dong W; Cheng Y; Zhou Y; Zhang J; Yu X; Guan H; Du J; Zhou X; Yang Y; Fang W; Wang X; Song H
    J Biol Chem; 2024 Apr; 300(4):107135. PubMed ID: 38447796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
    Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
    Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
    [No Abstract]   [Full Text] [Related]  

  • 11. Ets2 anchors the prometastatic function of mutant p53 in osteosarcoma.
    Liu DD; Kang Y
    Genes Dev; 2017 Sep; 31(18):1823-1824. PubMed ID: 29051386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of USP7 negatively regulates the stability of ETS proto-oncogene 2 protein.
    Park HB; Min Y; Hwang S; Baek KH
    Biomed Pharmacother; 2023 Jun; 162():114700. PubMed ID: 37062218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E26 Transformation-Specific Transcription Factor ETS2 as an Oncogene Promotes the Progression of Hypopharyngeal Cancer.
    Liu X; Zhang C; Zhang Z; Zhang Z; Ji W; Cao S; Cai X; Lei D; Pan X
    Cancer Biother Radiopharm; 2017 Nov; 32(9):327-334. PubMed ID: 29111780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.
    Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H
    Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETS2 and Twist1 promote invasiveness of Helicobacter pylori-infected gastric cancer cells by inducing Siah2.
    Das L; Kokate SB; Rath S; Rout N; Singh SP; Crowe SE; Mukhopadhyay AK; Bhattacharyya A
    Biochem J; 2016 Jun; 473(11):1629-40. PubMed ID: 27048589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
    Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
    Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.
    Lu G; Zhang Q; Huang Y; Song J; Tomaino R; Ehrenberger T; Lim E; Liu W; Bronson RT; Bowden M; Brock J; Krop IE; Dillon DA; Gygi SP; Mills GB; Richardson AL; Signoretti S; Yaffe MB; Kaelin WG
    Cancer Cell; 2014 Aug; 26(2):222-34. PubMed ID: 25117710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DET1 regulates the proteasomal degradation of LHY, a component of the Arabidopsis circadian clock.
    Song HR; Carré IA
    Plant Mol Biol; 2005 Mar; 57(5):761-71. PubMed ID: 15988568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and kinetics of the bimolecular complex formed by the tumor suppressor p53 with ubiquitin ligase COP1 as studied by atomic force microscopy and surface plasmon resonance.
    Moscetti I; Bizzarri AR; Cannistraro S
    Int J Nanomedicine; 2018; 13():251-259. PubMed ID: 29379285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.